HCW Biologics prices $1.5M private placement of units with warrants

HCW Biologics Inc.

903,614 units at $1.6599/unit; each includes pre-funded warrant (exercise $0.0001) and right to common warrant (exercise $1.66, 5.5-yr) subject to stockholder approval.
Gross proceeds ~$1.5M; net for clinical trial HCW9302, IND-enabling for HCW11-018b and HCW11-040, and general corporate purposes.
Maxim Group LLC sole placement agent; registration statement to be filed within 15 trading days of closing, effective within 60.
Pre-funded warrants carry 9.99% beneficial ownership cap; common warrants 4.99% cap, issuable only after Nasdaq Rule 5635(d) approval.

item 1.01 item 3.02 item 7.01 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.